Fox Chase Cancer Center

Michael Hall, MD, MS, director of gastrointestinal risk assessment and assistant professor at Fox Chase Cancer Center, was featured in an OncLive video on multigene target panels to determine genetic weaknesses.

Mary B. Daly, MD, PhD, FACP, chair of clinical genetics at Fox Chase Cancer Center, offered expert commentary to Hem/Onc Today about a JAMA Oncology study on prenatal testing to detect cancer in pregnant women.

Joining the likes of elephants, bears, alligators and tigers, Fox Chase Cancer Center faculty, staff and patients took charge at the Philadelphia Zoo on Sunday, August 16, 2015, at the first annual Miles for Melanoma 5K. The event was sponsored by the Melanoma Research Foundation.

The page compares protons and photons for prostate cancer, including their differences and how each targets localized tumors.

PHILADELPHIA (December 19, 2016) – Fox Chase Cancer Center has received a four-star rating from the Centers for Medicare and Medicaid Services (CMS) in its latest Hospital Care report.

Researchers from Fox Chase Cancer Center presented a study at the American Urological Association (AUA) Annual Meeting 2024 finding that numerical cutoffs did not improve accuracy over radiologist-read CT scans in assessing whether a mass was likely cancerous.

PHILADELPHIA (December 2, 2020)—In a recently published study, researchers at Fox Chase Cancer Center found that more elderly patients with localized head and neck cancer received multidisciplinary care compared with patients with advanced-stage disease.

PHILADELPHIA (March 10, 2020) — A 10-year update of a randomized, prospective study conducted by researchers at Fox Chase Cancer Center has found that conventional fractionated and moderate hypofractionated radiation therapy for localized prostate cancer were equally effective.

The page covers cancer treatments, clinical trials, and physicians at Fox Chase Cancer Center, an NCI center in Philadelphia.